Targeted next generation sequencing reveals high mutation frequency of CREBBP, BCL2 and KMT2D in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements

Haematologica. 2019 Apr;104(4):e154-e157. doi: 10.3324/haematol.2018.198572. Epub 2018 Oct 11.

Solène M Evrard^{1

2

3}, Sarah Péricart⁴, David Grand⁴, Nadia Amara⁴, Frédéric Escudié⁴, Julia Gilhodes⁵, Pierre Bories⁶, Alexandra Traverse-Glehen⁷, Romain Dubois⁸, Pierre Brousset^{4

2

3}, Marie Parrens⁹, Camille Laurent^{4

2

3}

¹ Pathology and Cytology Department, CHU Toulouse, IUCT Oncopole solene.evrard@univ-tlse3.fr.
² Toulouse III Paul Sabatier University.
³ Inserm, UMR1037 Centre de Recherche en Cancerologie de Toulouse, laboratoire d'excellence TOUCAN.
⁴ Pathology and Cytology Department, CHU Toulouse, IUCT Oncopole.
⁵ Department of Biostatistics, IUCT-Oncopole, CHU Toulouse.
⁶ Regional Cancer Network Onco-occitanie, IUCT-Oncopole, Toulouse.
⁷ Hospices Civils de Lyon, Claude Bernard Lyon 1 University, INSERM 1052, Pierre-Bénite.
⁸ Institut de Pathologie, CHU Lille, Avenue Oscar Lambret.
⁹ Pathology, CHU Bordeaux, Inserm U1053, France.

No abstract available

Publication types